Diagnostics News and Research

RSS

Ventana introduces BenchMark ULTRA with URA to process IHC, ISH samples

Ventana Medical Systems, Inc., a member of the Roche Group, announced today the launch of BenchMark ULTRA with new Ultimate Reagent Access.

3 Aug 2011

SDIX adds nine new polyclonal antibodies to IVD reagents portfolio

SDIX, a leading provider of In Vitro Diagnostic (IVD) reagents, announced the addition of nine new polyclonal antibodies to its product line for the IVD market while exhibiting at AACC last week.

3 Aug 2011

USPTO issues notice of allowance for Vermillion's PAD biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Beta-2 microglobulin as a Biomarker for Peripheral Artery Disease."

3 Aug 2011

Exact Sciences second quarter total revenues decreases to $1.0 million

Exact Sciences Corp. today announced its financial results for the quarter ended June 30, 2011.

2 Aug 2011

BD third quarter revenues increase to $2.014 billion

BD, a leading global medical technology company, today reported quarterly revenues of $2.014 billion for the third fiscal quarter ended June 30, 2011, representing an increase of 10.0 percent from the prior-year period.

From BD (Becton, Dickinson and Company) 2 Aug 2011

Merrimack receives FDA orphan drug status for MM-398 to treat pancreatic cancer

Merrimack Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted MM-398 orphan drug status for the treatment of pancreatic cancer.

2 Aug 2011

Tunstall Healthcare launch new myclinic@home telehealth solution

myclinic@home is the latest in telehealth solutions, allowing remote patients to easily monitor their vital signs and manage a long term health condition in the comfort of their own home or a clinic setting, all supported by a health professional.

1 Aug 2011

PathoGenetiX receives $4.0 million in first close of Series B financing

PathoGenetiX Inc., today announced that the Company has received $4.0 million in the first closing of its Series B financing.

1 Aug 2011

New device can produce blood-based diagnostic results in minutes

Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.

1 Aug 2011

Human genes can be patented in U.S. - Court overrules previous ruling

A lower court in the U.S. had earlier ruled that human genes cannot be patented by biotech companies who use them for diagnostic purposes. Now a federal appeals court ruled on Friday that genes can be patented. The Court of Appeals for the Federal Circuit, which specializes in patent cases, said that Myriad Genetics was entitled to patents on two human genes used to predict if women have an increased risk of getting breast and ovarian cancer.

31 Jul 2011

FDLI conference to discuss IOM study on 510(k) Clearance Process

On the heels of the release of the highly anticipated Institute of Medicine (IOM) report, Public Health Effectiveness of the FDA 510(k) Clearance Process, The Food and Drug Law Institute (FDLI) is holding a "Dialogue" on the report August 4 in Washington, D.C.

30 Jul 2011

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

30 Jul 2011

Human kinome RNAi screening performed using Roche’s xCELLigence MP Instrument

RNA interference studies are a powerful technology for high-throughput screening. However, endpoint analyses only provide a snapshot of the analyzed cellular phenotype, as it is not possible to measure developmental changes over time.

29 Jul 2011

Studies reveal new set of mutations linked with head and neck cancer

Powerful new technologies that zoom in on the connections between human genes and diseases have illuminated the landscape of cancer, singling out changes in tumor DNA that drive the development of certain types of malignancies such as melanoma or ovarian cancer.

29 Jul 2011

NanoString introduces new assay for leukemia fusion gene analysis

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the availability of a comprehensive multiplexed assay for the simple and cost-effective analysis of fusion genes linked to leukemia.

From NanoString Technologies 29 Jul 2011